FDA Decision-Making Should Focus On Relevance, Not Just Quantity, Of Data, NRC Says
This article was originally published in The Pink Sheet Daily
Executive Summary
A National Research Council committee provides FDA with a framework for comparing the public health consequences of alternatives when making risk-based decisions.